Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion

Indian Journal of Medical Research

Volumn 122, Issue 2, 2005, Pages 132-136

  Mittal, Suneeta ^a   Agarwal, Sonika ^a   Kumar, Sunesh ^a   Batra, Ashima ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Abortifacient efficacy; Duration of bleeding; Medical abortion; Misoprostol

Indexed keywords

MIFEPRISTONE; MISOPROSTOL; PLACEBO;

ABDOMINAL PAIN; ADULT; AMENORRHEA; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; NAUSEA; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SYNCOPE; THERAPEUTIC ABORTION; UTERINE BLEEDING PATTERN; VAGINA BLEEDING; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; DOUBLE-BLIND METHOD; FEMALE; HEMORRHAGE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; TIME FACTORS;

EID: 26044445944     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chhabra R, Nuna SC. Abortion in India - an overview. Delhi: Ford Foundation; 1994.
2. Karkal M. Abortion laws and the abortion situation in India. Reprod Genet Eng 1991; 4: 223-30.
3. World Health Organization Task Force on Postovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomized trial. Br J Obstet Gynecol 2000; 107: 524-30.
4. World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation. Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial. Acta Obstet Gynecol Scand 2001; 80: 447-51.
5. el-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983-7.
6. Gemzell-Dannielsson K, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 1999; 93: 275-80.
7. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999; 59: 1-6.
8. Davis A, Westhoff C, De Nonno L. Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration. J Am Med Womens Assoc 2000; 55 (Suppl 3): 141-4.
9. World Health Organization Task Force on Postovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993; 307: 532-7.
10. Harper C, Winikoff B, Ellertson C, Coyaji K. Blood loss with mifepristone-misoprostol abortion: measures from a trial in China, Cuba and India. Int J Gynecol Obstet 1998; 63: 39-49.
11. van Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I. Efficacy. Br J Obstet Gynecol 2003; 110: 808-18.
12. Coyaji K. Early medical abortion in India: three studies and their implications for abortion services. J Am Med Womens Assoc 2000; 55 (Suppl 3): 191-4.